semaj83/ctmatch_classification huggingface dataset:
Patient description: The patient is a 34-year-old obese woman who comes to the clinic with weight concerns. She is 165 cm tall, and her weight is 113 kg (BMI: 41.5). In the past, she unsuccessfully used antiobesity agents and appetite suppressants. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher. She is married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She rarely exercises and movement seems to be hard for her. She is not able to complete the four-square step test in less than 15 seconds. She does not smoke or use any drugs. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her lab results: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl She is considering a laparoscopic gastric bypass.

Clinical trial eligibility criteria: eligible ages (years): 18.0-70.0,  Weight Loss Obesity Diabetes Diet, Reducing Carbohydrates Protein Age: 18-70 years old Body mass index between 27.5 Steady weight (± 4 kg) in the last 2 months Glycated hemoglobin between 6  Anti-diabetic drugs (oral or subcutaneous) in the last 2 months Lipid-lowering drugs in the last 2 months Gouty arthritis in the last 2 years or uric acid > 735 mg/dl Presence of uncontrolled endocrinological pathology (including hypothyroidism) Hepatic chronic disease (glomerular filtration rate < 45 ml/min) Renal, inflammatory or tumoral diseases Drugs which could interfere in glucose or lipid metabolism such as androgens, corticosteroids (except for those with topic administration) and estrogen replacement therapy Intake of functional foods with plant sterols in the past 6 weeks High alcohol intake (> 30 g per day) Any serious disease which involves less than 1 year life expectancy or, in investigators judgment, limit the follow-up of an homogeneous diet throughout the study
Patient description: The patient is a 34-year-old obese woman who comes to the clinic with weight concerns. She is 165 cm tall, and her weight is 113 kg (BMI: 41.5). In the past, she unsuccessfully used antiobesity agents and appetite suppressants. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher. She is married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She rarely exercises and movement seems to be hard for her. She is not able to complete the four-square step test in less than 15 seconds. She does not smoke or use any drugs. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her lab results: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl She is considering a laparoscopic gastric bypass.

Clinical trial eligibility criteria: eligible ages (years): 18.0-64.0,  Abdominal Obesity BMI: > or equal to 25.0 kg/m2 and < or equal to 40 kg/m2 Waist Circumference: >102 cm (men) or > 88 cm (women) Any one of the other four defining risk factors defining metabolic syndrome (Triglycerides > or equal to 150 mg/dL , HDL Cholesterol < 40 mg/dL (men) or < 50 mg/dL (women), Resting blood pressure > or equal to 130 mm Hg systolic / 85 mm Hg diastolic, Fasting glucose > or equal to 110 mg/dL)  Systolic blood pressure > 179 mmHg and/or diastolic blood pressure > 99 mmHg Self-reported Type 1 or Type 2 diabetes, or use of diabetes-related medications Significant CVD or disorders Other significant medical conditions including but not limited to implants that may interfere with MRI, chronic respiratory, gastrointestinal, neuromuscular, or psychiatric conditions, malignancies in the past 5 years, with the exception of skin cancer therapeutically controlled, endocrine (including diabetes), any other medical conditions or disease (including arthritis) that is life threatening or that can interfere with or be aggravated by exercise Poor compliance to activity monitors
Patient description: The patient is a 34-year-old obese woman who comes to the clinic with weight concerns. She is 165 cm tall, and her weight is 113 kg (BMI: 41.5). In the past, she unsuccessfully used antiobesity agents and appetite suppressants. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher. She is married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She rarely exercises and movement seems to be hard for her. She is not able to complete the four-square step test in less than 15 seconds. She does not smoke or use any drugs. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her lab results: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl She is considering a laparoscopic gastric bypass.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Obesity Fatty Liver Age ≥ 18 years 2. Verbal and written fluency of the English Language 3. Able to consent  Absolute contraindications to MRI including pacemaker, automatic implantable cardioverter/defibrillator (AICD) device, cochlear implant, ventriculoperitoneal (VP) shunt, aneurysm clip, deep brain stimulator, and severe claustrophobia 2. Absolute contraindications to liver biopsy including coagulopathy 3. History of decompensated cirrhosis complicated by one or more of the following: esophageal variceal hemorrhage, ascites, hepatic encephalopathy, or spontaneous bacterial peritonitis. 4. Women who are pregnant or breastfeeding 5. History of liver transplantation or hepatic resection 6. History of primary or secondary hepatic malignancy 7. Current or previous excessive alcohol consumption within 6 months of study enrollment defined as > 30 grams/day for men and > 20 grams/day for women 8. Current or prior history of therapy for underlying liver disease including interferon-based medications, other antiviral agents, immunomodulatory therapy, biologic response modifier therapy, and complementary/alternative medications including (but not encompassing) milk thistle 9. Any severe medical condition that, in the opinion of the Principal Investigator, would serve as an criterion for study enrollment
Patient description: The patient is a 34-year-old obese woman who comes to the clinic with weight concerns. She is 165 cm tall, and her weight is 113 kg (BMI: 41.5). In the past, she unsuccessfully used antiobesity agents and appetite suppressants. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher. She is married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She rarely exercises and movement seems to be hard for her. She is not able to complete the four-square step test in less than 15 seconds. She does not smoke or use any drugs. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her lab results: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl She is considering a laparoscopic gastric bypass.

Clinical trial eligibility criteria: eligible ages (years): 20.0-40.0,  Postpartum Hemorrhage Women who accept to participate (either the patient or her first-kin if she is unconscious) 2. Primary atonic postpartum hemorrhage  Traumatic postpartum haemorrhage
Patient description: The patient is a 34-year-old obese woman who comes to the clinic with weight concerns. She is 165 cm tall, and her weight is 113 kg (BMI: 41.5). In the past, she unsuccessfully used antiobesity agents and appetite suppressants. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher. She is married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She rarely exercises and movement seems to be hard for her. She is not able to complete the four-square step test in less than 15 seconds. She does not smoke or use any drugs. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her lab results: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl She is considering a laparoscopic gastric bypass.

Clinical trial eligibility criteria: eligible ages (years): 18.0-85.0,  Hyperlipidemia Either gender, in general good health, between 25-85 years old 2. Serum TG 150-495 mg/dl at screening 3. Serum LDL >/= 70 mg/dl at screening 4. Not using any other product including drugs, medical foods, neutraceuticals or dietary supplements for control of serum lipids 5. Consistent dietary habits 6. Women of child bearing potential must use an accepted method of birth control 7. Able to read and understand study documents including the Subject Informed Consent Document (Spanish language translation available, if needed)  serum TG <150 or >495 mg/dl at screening visit 2. serum LDL<50 mg/dl at screening visit 3. use of any other serum lipid modifying agent (see section 6.0) within 4 weeks of screening visit 4. history of any intestinal disease that might interfere with absorption 5. history of pancreatitis, inflammatory colitis or prior cholecystectomy 6. any active malignancy or history of malignancy, except basal cell carcinoma or cervical carcinoma in situ curatively treated, within 3 years of the screening visit 7. screening AST, ALT, alkaline phosphatase, bilirubin >1.3 times the upper limit of normal for the reference laboratory 8. serum creatinine >2.0 9. uncontrolled diabetes mellitus (glycosylated Hgb >9) 10. diabetes mellitus not on stable therapy for at least 2 months 11. uncontrolled hypertension (DBP >100, SPB >160) 12. unstable angina, congestive heart failure or other uncontrolled cardiac disease 13. pregnant or lactating women 14. known history of allergies to O-3 fatty acids, carotenoids, vitamin E or fish products 15. history of substance abuse or any psychiatric condition that may impair the subject's ability to comply with the study requirements. 16. Regular consumption of more than one (1) unit of alcohol daily. For the purposes of this study a unit of alcohol consists of 12 oz. of beer, 6 oz. of wine or 2 oz of hard spirits. 17. any medical condition that, in the opinion of the investigator, might put the subject at undue risk or might interfere with the subject's ability to participate in the study 18. participation in another clinical trial within 30 days or 6 half lives of the study agent, whichever is longer, of the screening visit
Patient description: The patient is a 34-year-old obese woman who comes to the clinic with weight concerns. She is 165 cm tall, and her weight is 113 kg (BMI: 41.5). In the past, she unsuccessfully used antiobesity agents and appetite suppressants. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher. She is married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She rarely exercises and movement seems to be hard for her. She is not able to complete the four-square step test in less than 15 seconds. She does not smoke or use any drugs. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her lab results: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl She is considering a laparoscopic gastric bypass.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Stroke Prevention Blood Pressure Reduction Age ≥ 18 Clinical ischemic stroke, intracerebral hemorrhage, or transient ischemic attack Plan to discharge home or to short stay inpatient rehab after stroke Two of following required History of hypertension (prior to hospitalization) Hospital blood pressure ≥ 140/90 on two or more occasions during hospitalization Discharge home on blood pressure medication Willingness and ability to follow-up in University of Texas Physicians stroke clinic  Modified Rankin scale (mRs) > 3 at enrollment Terminal illness Chronic kidney disease stage 4 or greater (eGFR < 30) Pregnancy Symptomatic flow limiting carotid stenosis without plan for intervention prior to clinic visit Stroke etiology presumed unrelated to atherosclerotic risk factors (amyloid angiopathy, vasculitis, malignancy associated)
Patient description: The patient is a 34-year-old obese woman who comes to the clinic with weight concerns. She is 165 cm tall, and her weight is 113 kg (BMI: 41.5). In the past, she unsuccessfully used antiobesity agents and appetite suppressants. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher. She is married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She rarely exercises and movement seems to be hard for her. She is not able to complete the four-square step test in less than 15 seconds. She does not smoke or use any drugs. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her lab results: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl She is considering a laparoscopic gastric bypass.

Clinical trial eligibility criteria: eligible ages (years): 22.0-75.0,  Obesity Osteoarthritis Age 22-75 years Subject is diagnosed with Non-inflammatory Degenerative Joint Disease(NIDJD) Subject is diagnosed with Morbid Obesity (Body Mass Index ≥ 40 kg/m2 or >35 kg/m2 with qualifying comorbid conditions such as obstructive sleep apnea or diabetes) Subject is a suitable candidate for cemented primary TKA with either resurfaced or non-resurfaced patellae Subject is currently not bedridden Subject, in the opinion of the Clinical Investigator, is able to understand this clinical investigation and co-operate with investigational procedures Subject has given voluntary, written informed consent to participate in this clinical investigation Subject is comfortable with speaking, reading, and understanding questions and providing responses in an available translated language  Subject has undergone THA or contralateral knee within the past 6 months Subject has had a contralateral amputation Subject requires simultaneous bilateral TKA Previous partial knee replacement (unicompartmental, bicompartmental or patellofemoral joint replacement), patellectomy, high tibial osteotomy or primary TKA in affected knee Subject is currently experiencing radicular pain from the spine Subject was diagnosed with fibromyalgia that is currently being treated with prescription medication Subject has significant neurological or musculoskeletal disorders or disease that may adversely affect gait or weight bearing (e.g. muscular dystrophy, multiple sclerosis, Charcot disease) Subject is suffering from inflammatory arthritis (e.g. rheumatoid arthritis, juvenile rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus, etc.) Subject has had previous bariatric surgery Subject is medically or psychologically not suitable to undergo surgery
Patient description: The patient is a 34-year-old obese woman who comes to the clinic with weight concerns. She is 165 cm tall, and her weight is 113 kg (BMI: 41.5). In the past, she unsuccessfully used antiobesity agents and appetite suppressants. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher. She is married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She rarely exercises and movement seems to be hard for her. She is not able to complete the four-square step test in less than 15 seconds. She does not smoke or use any drugs. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her lab results: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl She is considering a laparoscopic gastric bypass.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Low Cardiac Output Pregnant patients with BMI of less than 30 undergoing elective CS. 2. Obese pregnant patients with BMI of more than 35 undergoing elective CS  Patients with other comorbidities like pre-eclampsia, eclampsia, essential hypertension, respiratory disease and compromised renal function. 2. Patients on long-term medication. 3. Patients having CS under epidural. 4. Patients having general anaesthesia. 5. Patients on antihypertensive medication. 6. Patients with BMI of 31-34. 7. Patients less than 36 weeks of gestation
Patient description: The patient is a 34-year-old obese woman who comes to the clinic with weight concerns. She is 165 cm tall, and her weight is 113 kg (BMI: 41.5). In the past, she unsuccessfully used antiobesity agents and appetite suppressants. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher. She is married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She rarely exercises and movement seems to be hard for her. She is not able to complete the four-square step test in less than 15 seconds. She does not smoke or use any drugs. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her lab results: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl She is considering a laparoscopic gastric bypass.

Clinical trial eligibility criteria: eligible ages (years): 30.0-40.0,  Obesity Gender: male and female Age: 30-40 years Diagnosis of obesity and normal weight according to WHO: Individuals with normal weight or BMI ≥ 18.5 to 24.9 kg / m2. Individuals with obesity or BMI ≥ 30 to 39.9 kg / m2. • Diagnosis absence of visceral obesity according to WHO: Normal Weight; waist circumference: Women <80 cm and men <90 cm. • Diagnosis of visceral obesity according to WHO: waist circumference: Women and men ≥ 80 cm ≥ 90 cm What are sedentary during the past three months. Individuals committed in 15-30 minutes of physical activity exclusively by at least 3 times a week at most No change in the oral glucose tolerance according to the ADA: or fasting glucose <100 mg / dL and afterload glucose <140 mg / dL. • written informed consent  Women pregnant or lactating Diagnosis of DM according to the ADA. Fasting glucose: ≥ 126 mg / dL glucose and afterload: ≥ 140 mg / dL Thyroid disease and / or hypertension Diagnosis of metabolic syndrome Consumption of oral agents or other medicines and supplements with proven properties that modify the behavior of glucose Liver enzymes: GOT and GPT concentrations twice normal Changes in GFR according to the Cockcroft and Gault, with levels below 60 mL / min / 1.73 m2, which is suggestive of chronic kidney disease Changes in serum lipid levels: Total cholesterol <200 mg / dL Triglycerides <150 mg / dL HDL-C > 60 mg / dL or LDL-C <130 mg / dL
Patient description: The patient is a 34-year-old obese woman who comes to the clinic with weight concerns. She is 165 cm tall, and her weight is 113 kg (BMI: 41.5). In the past, she unsuccessfully used antiobesity agents and appetite suppressants. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher. She is married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She rarely exercises and movement seems to be hard for her. She is not able to complete the four-square step test in less than 15 seconds. She does not smoke or use any drugs. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her lab results: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl She is considering a laparoscopic gastric bypass.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Pregnancy Repeat Cesarean Section Vaginal Births After Cesarean Women with exactly one prior Cesarean Delivery. 2. Current singleton pregnancy. 3. Gestational age, 12-24 weeks. 4. English or Spanish speaker. 5. Must be receiving prenatal care at one of the participating centers  Contraindications to vaginal delivery (e.g., placenta previa, prior classical cesarean, previous uterine rupture). 2. Prior VBAC
Patient description: The patient is a 34-year-old obese woman who comes to the clinic with weight concerns. She is 165 cm tall, and her weight is 113 kg (BMI: 41.5). In the past, she unsuccessfully used antiobesity agents and appetite suppressants. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher. She is married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She rarely exercises and movement seems to be hard for her. She is not able to complete the four-square step test in less than 15 seconds. She does not smoke or use any drugs. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her lab results: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl She is considering a laparoscopic gastric bypass.

Clinical trial eligibility criteria: eligible ages (years): 21.0-65.0,  Non-alcoholic Fatty Liver Disease (NAFLD) Weight Loss Non-alcoholic Steatohepatitis (NASH) Body mass index > 27.5 kg/m2 Waist circumference (WC) > 90 cm (male) or > 80 cm (female) Diagnosis of NASH based on Liver Function Test Results ,Ultrasound Hepato-Biliary System (HBS) findings and / or Liver Biopsy HbA1c < 8%* *Subjects in the bariatric surgery arm will not need to fulfil this criterion  Currently using insulin-sensitising agents (metformin, pioglitazone), weight loss medication (orlistat, phentermine). Patients taking any of these drugs will require a three month washout period before enrolment Pregnancy Significant cardiovascular or respiratory disease Renal impairment with eGFR < 60 ml/min Hepatitis B or C carrier, liver disease other than NAFLD History of pancreatitis Personal or family history of multiple endocrine neoplasia type 2 or thyroid carcinoma Untreated hypothyroidism or hyperthyroidism Current psychiatric illness Cardiac pacemaker, metallic prosthetic heart valves and other contraindications to MRI scan